Physician profile
Maroun M Tawk
NPI 1255300927
$61,540.25
in general payments reported to CMS, 2019-2025
53 companies · $2,643 in 2025
The $2,643 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $7,644 · 2021: $6,537 · 2022: $1,159 · 2023: $1,996 · 2024: $2,480 · 2025: $2,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,764 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,763.59 |
| Education | $354.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43,015.17 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Pfizer INC. | $5,029.77 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $3,659.23 | 2020-2024 | Camzyos, Eliquis |
| Insmed, INC. | $1,209.88 | 2021-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $1,074.37 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,014.66 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $748.60 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $670.06 | 2019-2025 | |
| Baxter Healthcare | $478.06 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $420.97 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $377.27 | 2020-2025 | Dupixent |
| Allergan, INC. | $342.36 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $284.93 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $245.54 | 2019 | |
| Abbvie INC. | $214.38 | 2022-2025 | Avycaz |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $209.31 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merck Sharp & Dohme LLC | $206.68 | 2020-2025 | Winrevair, Recarbrio, Zerbaxa |
| Fisher & Paykel Healthcare INC | $197.21 | 2023-2025 | Fisher & Paykel Healthcare |
| Harmony Biosciences LLC | $183.16 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $171.59 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $154.70 | 2021-2025 | Tezspire |
| Axsome Therapeutics, INC. | $150.73 | 2023-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $134.97 | 2023-2025 | Lumryz |
| Gilead Sciences, INC. | $123.96 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.72 | 2022-2025 | Glassia |
| Intuitive Surgical, INC. | $105.85 | 2025 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2020-2023 | |
| Genentech USA, INC. | $98.89 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $73.81 | 2022-2024 | Purified Cortrophin Gel |
| Advanced Respiratory, INC | $67.39 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $55.66 | 2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $50.71 | 2019-2025 | Ultomiris |
| United Therapeutics Corporation | $47.64 | 2025 | Tyvaso |
| Janssen Pharmaceuticals, INC | $46.43 | 2022 | |
| Mylan Specialty L.P. | $46.21 | 2019-2023 | Yupelri |
| Electromed, INC. | $39.61 | 2022-2025 | Smartvest |
| Circassia INC. | $36.77 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $33.25 | 2019 | |
| Inari Medical, INC. | $31.03 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Masimo Corporation | $29.08 | 2024 | |
| Shire North American Group INC | $28.52 | 2019 | |
| Pulmonx Corporation | $24.44 | 2024 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Paratek Pharmaceuticals, INC. | $21.88 | 2025 | Nuzyra |
| Lilly USA, LLC | $20.89 | 2025 | Zepbound |
| La Jolla Pharmaceutical Company | $18.52 | 2020 | |
| Shionogi INC | $18.09 | 2024 | Fetroja |
| Cumberland Pharmaceuticals, INC. | $16.93 | 2019 | |
| Viatris Specialty LLC | $16.43 | 2025 | Yupelri |
| Verona Pharma, INC. | $16.15 | 2025 | Ohtuvayre |
| Portola Pharmaceuticals, LLC | $15.85 | 2019 | |
| Vyera Pharmaceuticals, LLC | $14.92 | 2019 | |
| Phadia US INC. | $14.29 | 2024 | Immunocap |
| Tetraphase Pharmaceuticals, INC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maroun Tawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.